SpringWorks Therapeutics (NASDAQ:SWTX) Lowered to “Hold” Rating by Evercore ISI
Evercore ISI lowered shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) from a strong-buy rating to a hold rating in a report released on Monday,Zacks.com reports. A number of other research firms have also commented on SWTX. HC Wainwright restated a “buy” rating and issued a $74.00 price target on shares of SpringWorks Therapeutics in […]
Evercore ISI lowered shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) from a strong-buy rating to a hold rating in a report released on Monday,Zacks.com reports. A number of other research firms have also commented on SWTX. HC Wainwright restated a “buy” rating and issued a $74.00 price target on shares of SpringWorks Therapeutics in […]
